Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Oakmark U.S. Strategy backs high-conviction value picks like Schwab and Capital One. See how disciplined investing is driving ...

The Department for Work and Pensions (DWP) has released a vital message about a significant date approaching in under two ...

Digital technology was sold as a liberating tool that could free individuals from state power. Yet the state security ...